As part of the global effort towards a better understanding of the infection mechanisms of SARS-CoV-2, we have reported here a surface plasmon resonance (SPR)-based approach allowing for the kinetic evaluation of ACE2 binding to various SARS-CoV-2 RBDs. Our experimental approach allowed us to depict the data with a 1:1 Langmuir kinetic model and thus draw reliable and meaningful conclusions about the impact of key RBD mutations. Several studies have already employed SPR biosensing to analyze the interaction of SARS-CoV-2 variants to ACE2, but different experimental approaches resulted in a wide range of thermodynamic and kinetic constants (KD varying from 4 to 80 nM) that are difficult to compare from one study to the other 3,7−12. In fact, the choice of the ligand (proteins captured at the biosensor surface), the capture strategy, the ligand density, the flowrate, and the experimental temperature all may affect the recorded data and thus bias the interpretation 22. The experimental conditions must be optimized to minimize potential artifacts such as mass transport limitations, avidity, steric hindrance, and rebinding 23.
In this endeavor, our strategy was to focus only on the RBD region instead of using the complete spike protein ectodomain since its trimeric nature may introduce potential artifacts in the kinetic analysis 12,24. The spike protein is a large trimeric glycoprotein (~ 550 kDa) bearing three RBDs all capable to interact with an ACE2 receptor. This complex, spike / ACE2, is thus prone to avidity and rebinding artifacts in SPR-based assays. Moreover, it has been shown that each RBD can individually be either in an up or down conformation which influence the overall spike affinity for ACE2 and add a heterogeneity bias in the analytes of the SPR-based assay [23]. The proportion of RBD in each conformation can vary for different variants leading to even more complexity in the analysis of the spike / ACE2 interaction 24,25. Conducting SPR-based assay with the RBD as the analyte limits these biases and simplify the kinetic profiles of the data collected, as the RBD / ACE2 follows, in theory, a 1:1 binding model as we were able to observe at 10°C. It is then easier to obtain good quality and robust data to better understand the subtle affinity differences between SARS-CoV-2 variants and the ACE2 receptor.
Also, we chose to use ACE2 as the ligand, to better mimic the biological course of action where the virus interacts with ACE2 exposed at the surface of human cells. We optimized our SPR-based assay by tethering ACE2 onto the biosensor surface in a highly stable and oriented manner. Our coiled-coil mediated strategy allowed us to capture a constant low density of fresh ACE2-E5 at the surface for each experimental cycle; a low density of ligands on the surface reduces the risk of mass transport limitations and rebinding artefacts, which affect the kinetic interpretation of the data 26,27.
The immobilization strategy is also a determinant factor in SPR for stable and reproducible results. Studies relying on an amine covalent coupling approach are subject to heterogeneous immobilized ligand orientations and progressive loss of bioactivity over time and regeneration steps, which can translate into more complex kinetics and variable results 28. The oriented immobilization of the ligand by a capture agent (such as the coiled-coil peptide system) enables more control and flexibility over the density of ligand on the surface and guaranties the structural integrity of the ligand 23,29. Our coiled-coil approach proved to be simple and highly reproducible as we were able to obtain robust and reproducible results over five different sensor chips. The wild type (n = 5) and Alpha variants (n = 6) were our controls for every new sensor chip and showed minimal standard deviations on the calculated constant of affinity KD at 10°C (2.56 ± 0.35 nM for wild type and 0.18 ± 0.03 nM for Alpha).
We also varied the experimental temperature and underlined the importance of this parameter on the measurements of simple kinetics for the RBD / ACE2 interactions. At 37°C, although this temperature is interesting to better understand / mimick the molecular interactions during infection, the interaction kinetics were fast and deviated from a 1:1 kinetic model. This complexity can be attributed to an enhanced mobility and conformation change of the RBD loop interacting with ACE2 at higher temperatures 24,30,31. Other research groups performed their analysis at 25°C, which is the most common temperature in SPR-based assays 9,32. We were able to obtain acceptable fits with a 1:1 Langmuir binding model at 25°C but slowing the kinetics at an even lower temperature, i.e. 10°C, enabled us to observe excellent fits and enhanced the differences between the variants, better highlighting the impact of RBD mutations on ACE2 binding. We report comparable association rate constants between the Alpha, Beta and Omicron variants resulting in ~ 2.5 to 3-time faster binding than the wild type RBD (kon = 1.8 ± 0.3 x105 M− 1. s− 1, Table 2). The differences were more apparent in the dissociation rates where the Omicron and the Alpha presented the slowest rates at 0.57 ± 0.02 x10− 4 s− 1 and 0.79 ± 0.08 x10− 4 s− 1 respectively, which is 5 to 8 times slower than the wild type RBD. Meanwhile, the dissociation rate of the Beta variant is only 2 times slower. These kinetics confer the Omicron and the Alpha RBD variants with the highest affinities for ACE2, with ~ 20- and 15-fold decreases in KD compared to the wild type RBD, respectively. Several studies have reported an increased affinity for the Alpha variant binding to ACE2 similar to our findings at 25°C (~ 10-fold), and 37°C (~ 7-fold) 3,11,17,32. This increased affinity is linked to the only RBD mutation, N501Y 33,34. In fact, Tian et al. demonstrated that the enhancement of the affinity of RBD / ACE2 interaction results from the ability of the RBD mutant tyrosine sidechain to perform π-stacking interactions with the Y41 sidechain of ACE2 17.
The observed binding enhancement for the Omicron variant, however, is more complex to dissect due to the high number of mutations present at the interface with ACE2. Recent in silico models highly suggest that four key mutations contribute to this stronger interaction: S477N, G496S, Q498R and N501Y 35. Other point mutations, such as H505Y and K417N, were observed to negatively impact the interactions with ACE2, which modulates the affinity to a similar level to that of the Alpha variant 36–38. Further work is still needed to understand the individual and/or combine influence of Omicron mutations on its affinity for ACE2.
The effect of the K417N mutation is more predominant for the Beta RBD-ACE2 complex where this RBD variant expresses two additional mutations: E484K and N501Y. The positive effect of the N501Y mutation seems to be counteracted by the K417N mutation, resulting in only a 5-fold affinity enhancement compared to the wild type at 10°C (Fig. 3). In fact, the replacement of the lysine at position 417 by an asparagine disables the formation of a salt bridge between RBD K417 and ACE2 D30 in the wild type RBD / ACE2 complex 39. The absence of this salt bridge translates to a decreased affinity as observed in this work (Fig. 4) and in several other studies 7,32,40. Our study shows that the E484K mutation has no significant impact on the binding affinity to ACE2, while other studies have reported conflicting results 9,35,41.
The AlphaP (L452R/N501Y), Delta (L452R/T478K) and Kappa (L452R/E484Q) variants all presented faster association and dissociation rates at all temperatures. They also exhibited a lower affinity for ACE2, i.e., 5-, 40- and 10-fold decreases respectively compared to the wild type, at 10°C. Based on these results, we could infer that the L452R mutation disturbs the binding to ACE2 and that, while it is compensated by the N501Y mutation in AlphaP, its effect is more apparent in Delta and Kappa. These results contrast with some studies that measured similar or slightly higher affinities for these variants compared to wild type 42,43. However, the impact of L452R mutation on the RBD / ACE2 interaction is still debated as several studies demonstrated that it does not play a major role in the interaction with ACE2 5,44,45. In fact, some have suggested that the L452R mutation abrogates a hydrophobic patch formed by the amino acids L452, L492 and F490 46. The loss of this patch could impact stability of the RBD and possibly its complexation with ACE2, as suggested by our results. Moreover, L452 is not directly engaged with any ACE2 residue, which led research groups to focus on its impact on binding to antibodies instead of ACE2. A recent study showed that the L452R mutation enhances the viral replication by increasing the S protein stability and viral infectivity 47. Moreover, the second mutation (E484Q) in the Kappa variant was also shown to weakly affect its interaction with ACE2. E484 only weakly interacts with ACE2 K31 and its substitution by a glutamine residue decreases binding 46. Both mutations, L452R and E484Q are not involved in the interaction with ACE2, as shown for the other mutations, and most studies have linked them to an enhanced immune evasion from neutralizing antibodies 39,48−51. However, the T478K mutation on Delta has been linked to a higher affinity for ACE2 due to the introduction of a positive charge on the lysine residue 52. Some studies have shown, in the context of a trimeric spike construct, that the apparition of a positive electrostatic charge from T478K mutation stabilizes the RBD and favors its up conformation, leading to a better interaction with ACE2 30,31,43.
Thermodynamic differences were also apparent in the enthalpic and entropic values measured by Van’t Hoff plots for the AlphaP and Kappa. Enthalpic changes favor binding in all cases, as is inferred from a negative \(\varDelta H^\circ\), indicative of an exothermic reaction. Amongst the variants that were studied, Alpha, Beta and Omicron showed the most exothermic behavior, whereas enthalpic contributions were the weakest for Kappa and AlphaP. Entropic contributions showed the opposite trend. They were shown to hamper binding to ACE2 for Alpha, Beta, Delta and Omicron (and wild type) whereas they contributed to the stability of the RBD / ACE2 complex for Kappa and AlphaP. The L452R mutation could be in part responsible for the opposite trends in enthalpic and entropic changes, as it is common to both Kappa and AlphaP. The L452R impact on Delta RBD / ACE2 thermodynamic values could be balanced by the T478K mutation which integrates a second positive charge and was shown to contribute to RBD conformation stabilization 31,49.
Our optimized SPR-based assay showed to be a robust approach to better reveal subtle changes in kinetic and thermodynamic data defining the interaction between the RBD of SARS-CoV-2 variants and human ACE2. We also took advantage of this assay to look at the impact of ACE2 glycosylation profiles upon RBD binding, as both ACE2 and RBD / spike are glycoproteins and it has been suggested that RBD and ACE2 glycans may contribute to binding stabilization 33,53,54. At 10°C, we observed slight differences, i.e., less than 1.5-fold, between afucosylated ACE2 glycoforms, (F15, dKO2 and dKO2/ST6) and the WT ACE2 produced in CHO cells. To the best of our knowledge, no other studies observed an influence from fucosylation. Our results did not show a detectable influence from sialylation on the affinity between ACE2 and the wild type RBD. Other studies report a decreased affinity between sialylated ACE2 glycoforms with SARS-CoV-2 SPIKE protein 54–56. Therefore, it would be interesting to further increase the sialylation level of ACE2 to see its impact using our enhanced SPR assay at low temperature. Moreover, the RBD region only harbor two N-glycosylation and up to 5 O-glycosylation sites 57 while the S1 domain of the spike protein contains 13 N-glycans. It may thus be of interest to adapt this SPR assay to the S1 domain.
In summary, we present an optimized SPR-based assay to enhance our understanding of the binding mechanisms between SARS-CoV-2 RBD and the human ACE2. The use of the K5/E5 coiled-coil tethering strategy resulted in a high reproducibility in our results while a low experimental temperature of 10°C enabled us to collect data depicted by a simple 1:1 Langmuir kinetic model. Altogether, this allowed us to precisely characterize the interactions of SARS-CoV-2 RBD variants with ACE2. This approach could be used to rapidly compare new variants of concern to those reported here and infer on their capacity to infect human cells.